Swine Vaccines Market Trends, Size, Growth Drivers, Revenue, Demand and Future Outlook
Swine Vaccines Market Growth, Size, Trends Analysis - By Product, By Disease Type, By Route of Administration, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Mar-2025 | Report ID: HLCA2593 | Pages: 1 - 272 | Formats*: |
| Category : Healthcare | |||
Swine Vaccines Market Introduction and Overview
According to SPER Market Research, the Global Swine Vaccines Market is estimated to reach USD 3.07 billion by 2034 with a CAGR of 5.77%.
The report includes an in-depth analysis of the Global Swine Vaccines Market, including market size and trends, product mix, Applications, and supplier analysis.
The market for swine vaccines is fuelled by the increased incidence of swine illnesses, rising pork demand, and expanding animal health consciousness. Successful immunization campaigns contribute to the prevention of disease outbreaks such as foot-and-mouth disease and porcine reproductive and respiratory syndrome (PRRS), which accelerates market expansion. Further supporting expansion are technological developments in vaccine development, such as DNA and recombinant vaccines. Market expansion is hampered, meanwhile, by issues like expensive vaccine development, strict regulatory clearances, and restricted vaccination availability in poorer nations. Obstacles include worries about adverse reactions and the ineffectiveness of vaccines against new strains. The market is still expanding despite these obstacles as a result of rising R&D expenditures.
By Product Insights: Swine Vaccines is classified into three categories based on Product: Modified/Attenuated Live, Inactivated (Killed) and others. The market leader with the most revenue share was the Inactivated (Killed) segment. This is explained by its affordability, ease of access, and stability benefits over live-attenuated vaccinations. According to projections, the other segment will grow at the quickest rate throughout the predicted period. It is expected that vaccines like recombinants, which can include many gene inserts, will help achieve vaccination against a variety of virus strains.
By Disease Type Insights: The market for Swine Vaccines is segmented based on Disease Type, including Swine Influenza, Classical Swine Fever, Porcine Parvovirus, Porcine Circovirus Type 2, M.Hyo, Actinobacillus Pleuropneumonia, PRRS, Foot & Mouth Disease, Pseudorabies, PEDV. The market leader with the biggest revenue share was Porcine Reproductive and Respiratory Syndrome, or PRRS. Its widespread occurrence in major pig-raising nations is the reason behind this. It is projected that during the forecast period, the FMD category would see the quickest CAGR. Growth is anticipated to be fuelled most quickly by the growing emphasis on FMD prevention, especially in pig farming areas.
By Route of Administration Insights: The market for Swine Vaccines is segmented based on Route of Administration, including Injectables, Intranasal. The market leader with the most revenue share was the injectable sector. This is because of its efficacy and efficiency in offering pigs sustained defense against serious illnesses. Due to the growing use of products like Enterisol Ileitis, a live vaccination administered orally through the water supply, the oral segment is anticipated to grow at the quickest CAGR throughout the projection period.
By Distribution Channel Insights: The market for Swine Vaccines is divided based on Distribution Channel, including Retail, E-Commerce and Hospital/Clinic Pharmacies. The segment with the highest revenue share was hospital/clinic pharmacies. This is because of their direct interaction with end users, prompt vaccination services, and all-inclusive healthcare solutions, which guarantee prompt vaccine delivery and efficient disease control in the cattle industry. Over the course of the forecast period, the e-commerce sector is anticipated to grow at the quickest CAGR. Because they want easy access to a wider variety of vaccine goods, pig farmers and veterinarians are increasingly using digital platforms, which is driving this increase.
By Regional Insights: The swine vaccination market was controlled by North America. This is ascribed to the introduction of novel combination vaccines and the region's sophisticated veterinary treatment system. Boehringer Ingelheim Animal Health Canada Inc., for example, developed a novel vaccination that offers pigs protection against both PCV2 and PRRSv in a single dosage. A novel purification method made this breakthrough possible, allowing Ingelvac CircoFLEX and Ingelvac PRRS MLV to be mixed seamlessly without sacrificing effectiveness.
Market Competitive Landscape
Many small and large businesses have caused the industry to become rather fragmented and competitive. Furthermore, businesses are using a variety of tactics to increase their market shares, including product launches, geographic expansions, and mergers and acquisitions. Some of the key market players are Biogenesis Bago, Bioveta a.s, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Incorporated, HIPRA, Indian Immunologicals Limited, Merck & Co., Inc., Phibro Animal Health Corporation and Vaxxinova.
Recent Developments:
- In September 2024, The EMA granted Merck & Co., Inc. marketing approval for the intradermal swine vaccination PORCILIS PCV M Hyo ID. These standards promote overall pig health and aid in market expansion.
- In July 2024, The FDA and DA BAI confirmed the clearance of South Africa's first ASF vaccine, marking a significant advancement in the fight against African Swine Fever (ASF) with the goal of stabilizing the pig industry and protecting the meat supply chain.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Disease Type, By Route of Administration, By Distribution Channel. |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | Biogenesis Bago, Bioveta, a.s, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Incorporated, HIPRA, Indian Immunologicals Limited, Merck & Co., Inc., Phibro Animal Health Corporation, Vaxxinova. |
Key Topics Covered in the Report
- Global Swine Vaccines Market Size (FY’2021-FY’2034)
- Overview of Global Swine Vaccines Market
- Segmentation of Global Swine Vaccines Market By Product (Modified/Attenuated Live, Inactivated (Killed), Others)
- Segmentation of Global Swine Vaccines Market By Disease Type (Swine Influenza, Classical Swine Fever, Porcine Parvovirus, Porcine Circovirus Type 2, M.Hyo, Actinobacillus Pleuropneumonia, PRRS, Foot & Mouth Disease, Pseudorabies, PEDV)
- Segmentation of Global Swine Vaccines Market By Route of Administration (Injectables, Intranasal)
- Segmentation of Global Swine Vaccines Market By Distribution Channel (Retail, E-Commerce, Hospital/Clinic Pharmacies)
- Statistical Snap of Global Swine Vaccines Market
- Expansion Analysis of Global Swine Vaccines Market
- Problems and Obstacles in Global Swine Vaccines Market
- Competitive Landscape in the Global Swine Vaccines Market
- Details on Current Investment in Global Swine Vaccines Market
- Competitive Analysis of Global Swine Vaccines Market
- Prominent Players in the Global Swine Vaccines Market
- SWOT Analysis of Global Swine Vaccines Market
- Global Swine Vaccines Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPERs internal database2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Swine Vaccines Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Swine Vaccines Market
7. Global Swine Vaccines Market, By Product 2021-2034 (USD Million)
7.1. Modified/Attenuated Live7.2. Inactivated (Killed)7.3. Others
8. Global Swine Vaccines Market, By Disease Type 2021-2034 (USD Million)
8.1. Swine Influenza8.2. Classical Swine Fever8.3. Porcine Parvovirus8.4. Porcine Circovirus Type 28.5. M.Hyo8.6. Actinobacillus Pleuropneumonia8.7. PRRS8.8. Foot & Mouth Disease8.9. Pseudorabies8.10. PEDV
9. Global Swine Vaccines Market, By Route of Administration 2021-2034 (USD Million)
9.1. Injectables9.2. Intranasal
10. Global Swine Vaccines Market, By Distribution Channel 2021-2034 (USD Million)
10.1. Retail10.2. E-Commerce10.3. Hospital/Clinic Pharmacies
11. Global Swine Vaccines Market, 2021-2034 (USD Million)
11.1. Global Swine Vaccines Market Size and Market Share
12. Global Swine Vaccines Market, By Region, 2021-2034 (USD Million)
12.1. Asia-Pacific
12.1.1. Australia12.1.2. China12.1.3. India12.1.4. Japan12.1.5. South Korea12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France12.2.2. Germany12.2.3. Italy12.2.4. Spain12.2.5. United Kingdom12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia12.3.2. United Arab Emirates12.3.3. Qatar12.3.4. South Africa12.3.5. Egypt12.3.6. Morocco12.3.7. Nigeria12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada12.4.2. Mexico12.4.3. United States
12.5. Latin America
12.5.1. Argentina12.5.2. Brazil12.5.3. Rest of Latin America
13. Company Profile
13.1. Biogenesis Bago
13.1.1. Company details13.1.2. Financial outlook13.1.3. Product summary13.1.4. Recent developments
13.2. Bioveta, a.s.
13.2.1. Company details13.2.2. Financial outlook13.2.3. Product summary13.2.4. Recent developments
13.3. Boehringer Ingelheim International GmbH
13.3.1. Company details13.3.2. Financial outlook13.3.3. Product summary13.3.4. Recent developments
13.4. Ceva Sante Animale
13.4.1. Company details13.4.2. Financial outlook13.4.3. Product summary13.4.4. Recent developments
13.5. Elanco Animal Health Incorporated
13.5.1. Company details13.5.2. Financial outlook13.5.3. Product summary13.5.4. Recent developments
13.6. HIPRA
13.6.1. Company details13.6.2. Financial outlook13.6.3. Product summary13.6.4. Recent developments
13.7. Indian Immunologicals Limited
13.7.1. Company details13.7.2. Financial outlook13.7.3. Product summary13.7.4. Recent developments
13.8. Merck & Co., Inc.
13.8.1. Company details13.8.2. Financial outlook13.8.3. Product summary13.8.4. Recent developments
13.9. Phibro Animal Health Corporation
13.9.1. Company details13.9.2. Financial outlook13.9.3. Product summary13.9.4. Recent developments
13.10. Vaxxinova
13.10.1. Company details13.10.2. Financial outlook13.10.3. Product summary13.10.4. Recent developments
13.11. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
The North America is anticipated to have the highest Market share in the Swine Vaccines Market.
The key players in the Market include Companies Covered Biogenesis Bago, Bioveta, a.s, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Incorporated, HIPRA, Indian Immunologicals Limited, Merck & Co., Inc., Phibro Animal Health Corporation, Vaxxinova.
The market for swine vaccines is fuelled by the increased incidence of swine illnesses, rising pork demand, and expanding animal health consciousness. Successful immunization campaigns contribute to the prevention of disease outbreaks such as foot-and-mouth disease and porcine reproductive and respiratory syndrome (PRRS), which accelerates market expansion.
Swine Vaccines Market is projected to reach USD 3.07 billion by 2034, growing at a CAGR of 5.77% during the forecast period.
Swine Vaccines Market grew in Market size from 2025. The Market is expected to reach USD 3.07 billion by 2034, at a CAGR of 5.77% during the forecast period.
Swine Vaccines Market CAGR of 5.77% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Swine Vaccines Market size is USD 3.07 billion from 2025 to 2034.
Swine Vaccines Market is covered By Product, By Function, By Application, By End-User.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
